Cutaneous drug eruptions associated with COVID-19 therapy

Cutaneous drug eruptions associated with COVID-19 therapy

Bibliographic Details
Main Authors:	Laura Atzori, MD, Stefania Perla, MD, Maria Giovanna Atzori, MD, Caterina Ferreli, MD, Franco Rongioletti, MD
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	JAAD International
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666328720300201

Similar Items

Glomeruloid reactive angioendotheliomatosis in a woman with systemic lupus erythematosus and antiphospholipid syndrome mimicking reticular erythematous mucinosis
by: Caterina Ferreli, MD, et al.
Published: (2021-02-01)

Don't forget about syphilis: sexually transmitted diseases during COVID-19 pandemic
by: Andrea Di Buduo, et al.
Published: (2020-12-01)

Primary Localized Cutaneous Nodular Amyloidosis and Limited Cutaneous Systemic Sclerosis: Additional Cases with Dermatoscopic and Histopathological Correlation of Amyloid Deposition
by: Laura Atzori, et al.
Published: (2021-07-01)

Palmoplantar lichenoid drug eruption following the administration of Pfizer-BioNTech COVID-19 vaccine
by: Giovanni Paolino, MD, PhD, et al.
Published: (2022-03-01)

Childhood erythrodermic lichen planus pemphigoides after nonavalent human papillomavirus vaccination
by: Laura Pizzatti, MD, et al.
Published: (2020-05-01)

Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case Series
by: Maria Francesca Peigottu, et al.
Published: (2021-08-01)

Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy
by: Salma El-Behaedi, BS, et al.
Published: (2022-11-01)

Cutaneous pseudolymphomatous drug eruption secondary to supplemental flaxseed oil
by: Emma L. Larson, MD, et al.
Published: (2022-09-01)

Widespread and eruptive comedonal lesions with alopecia
by: Giovanni Paolino, MD, PhD, et al.
Published: (2023-01-01)

Cutaneous eruptions associated with monkeypox virus infection: A systematic review
by: Saleh Asaad, MD, et al.
Published: (2023-09-01)

Cutaneous eruption in neonate with congenital heart defect
by: Justin Raman, BS, et al.
Published: (2022-10-01)

Novel cutaneous eruptions in the setting of programmed cell death protein 1 inhibitor therapy
by: Rohan Mital, BS, et al.
Published: (2023-01-01)

Granulomatous drug eruption associated with imipramine
by: Anabella Pascucci, MD
Published: (2018-03-01)

Sudden-onset painful eruption of the hands: A cutaneous chimeric antigen receptor T-cell therapy reaction
by: Jimena A. Miranda, MD, et al.
Published: (2023-10-01)

Severe recalcitrant cutaneous eruption with dual immune checkpoint blockade
by: Sakeena Fatima, BA, et al.
Published: (2018-04-01)

Inverse lichenoid drug eruption associated with nivolumab
by: Lauren M. Guggina, MD, et al.
Published: (2017-01-01)

Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus
by: Soundos Youssef, MD, et al.
Published: (2023-07-01)

Cutaneous eruption associated with Streptococcus dysgalactiae (group C Streptococcus) bacteremia
by: Hovik J. Ashchyan, BA, et al.
Published: (2017-09-01)

Psoriasiform eruption on the face and extremities associated with nivolumab therapy
by: Amit Om, MD, et al.
Published: (2018-05-01)

A case of lichenoid drug eruption associated with relugolix
by: Joseph Han, BS, et al.
Published: (2023-03-01)

A case of primary cutaneous marginal zone lymphoma presenting with rosacea-like eruption
by: Tanvir Agnihotri, BA, et al.
Published: (2020-09-01)

Nicotine-induced bullous fixed drug eruption
by: Brynn Sargent, BS, et al.
Published: (2022-11-01)

Lichenoid drug eruption induced by erenumab
by: Meryl Musicante, BS, et al.
Published: (2023-02-01)

Obesity-Associated Lymphedematous Mucinosis: Two Further Cases and Review of the Literature
by: Caterina Ferreli, et al.
Published: (2018-02-01)

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19
by: Netana H. Markovitz, MD, et al.
Published: (2022-09-01)

Florid cutaneous morbilliform eruption in the setting of primary Epstein-Barr virus infection
by: Shahin A. Saberi, BS, et al.
Published: (2024-03-01)

Pityriasis rosea and pityriasis rosea-like eruptions after COVID-19 vaccines
by: Francesco Drago, MD, et al.
Published: (2022-12-01)

Galcanezumab-induced fixed drug eruption
by: Skylar Klager, SM, et al.
Published: (2021-03-01)

Reactive infectious mucocutaneous eruption following COVID-19 infection in vaccinated patients
by: Michael Aw, BSc, et al.
Published: (2023-01-01)

Formation of eruptive cutaneous squamous cell carcinomas after programmed cell death protein-1 blockade
by: Rachel L. Marsh, BA, et al.
Published: (2020-05-01)

How to manage drug-virus interplay underlying skin eruptions in children
by: Francesca Mori, MD, PhD, et al.
Published: (2024-03-01)

Viral Infections and Cutaneous Drug-Related Eruptions
by: Eleonora Anci, et al.
Published: (2021-03-01)

Blaschkolinear acquired inflammatory skin eruption (blaschkitis) following COVID-19 vaccination
by: Roger Rovira-López, MD, et al.
Published: (2022-08-01)

Use of photodynamic therapy and acitretin in generalized eruptive keratoacanthoma of Grzybowski
by: Stephanie Mlacker, MD, et al.
Published: (2017-09-01)

Umbilicated vesicles and multiple pustules on the genital area in a man
by: Klaus Eisendle, MD, et al.
Published: (2023-03-01)

A case of bullous fixed drug eruption caused by tadalafil
by: Jane Sun Zhang, MD, et al.
Published: (2024-03-01)

The Impact of the COVID-19 Pandemic on Cutaneous Drug Eruptions in a Swedish Health Region without Lockdown
by: Maria Pissa, et al.
Published: (2023-07-01)

Cutaneous manifestations of COVID-19 in a tertiary COVID-19 referral hospital in the PhilippinesCapsule Summary
by: Cyrene C. Tan, MD, et al.
Published: (2022-06-01)

Giant annular lichenoid drug eruption caused by efavirenz therapy
by: Emily Baumrin, MD, et al.
Published: (2018-04-01)

Pruritic postoperative eruption
by: Alexander L. Kollhoff, MD, et al.
Published: (2022-11-01)